Mushrooms Inc.
(OTC:
MSRM) Announces Plan for Acquisitions and Vertically Integrated
Business Development by Partnering with diversified Mushroom Market
Leaders
ESTERO, FL -- February
23, 2023 -- InvestorsHub NewsWire -- Mushrooms, Inc. (OTC:
MSRM) (the "Company") has been quietly making
progress within this exciting multi-billion-dollar
market opportunity currently being
opened by new mycelium-based materials science and
biotechnology.
Mushrooms Inc. is developing profitable pathways to
sustain the research and development branch which is necessary to
achieve viable industrial innovation in this new
field.
MSRM is targeting grants specific
to their goals, working with pioneers, scientists, and
universities, on a global scale to develop scientifically
proven products that advance health of
body, mind, and environment. They have multiple proposals that they are
currently reviewing for their costs to bring to market, timelines,
scalability, as well as their positive financial, environmental and
health impact. These proposals include a patentable process for the
development of mycelium-based building supplies, a patentable
process for mushroom related cosmetic and anti-aging skin products,
a superfood product not currently seen in the marketplace as well
as several remediation projects with new product innovation as an
end result. These proposals are being assessed while keeping the
progress on an off-shore lab and scientists for an evolved
patentable mycelium thread.
GROWTH
STRATEGY
In order to offset research costs
and time on the industrial development side we
are establishing pillars of development outside of
the industrial mushroom market through acquisitions and joint
ventures. The business model is based on the amazing
qualities of mycelium and its networking capabilities as well as
its ability to benefit from the network its
developing.
CEO Kimberly Carlson shared, "I
have been fortunate to connect with amazing pioneers and innovators
in differing areas of the Mushroom Market in the US and abroad.
Three realities have been consistent with the people behind the
businesses and their processes. One is that this business model can bring
like-minded companies together in order to benefit and fruit from a
shared network under the public umbrella. Secondly, there are natural and substantial
cross-points between these companies to mutually benefit from each
other while growing as a whole. And the third is that there is a
desire for many of these businesses to unite their expertise to
others and share from a unified gain. By
combining the power of shared ideals and resources through joint
ventures, we can move as larger more developed companies do, but
without limiting quality and compassion for social and
environmental governance."
With a focus on profitability and
mutually beneficial cross points, MSRM is assessing partnerships
with complimentary businesses which would strategically advance the
Company's reach into related markets through joint ventures and
M&A activity.
Establishing pillars of development
outside of the industrial mushroom market allows for a broad scope
of proven profitability and cross-sharing of
resources.
We seek to enter partnerships in
the Cultivation Market, which includes substrate, spawn production,
and fruiting. Cultivation gives life to all market pillars to some
degree. It feeds directly into the Mushroom Nutraceutical and
Medicinal Psylocibin Market with the addition of extraction,
quality testing, product development, and processing. The Medicinal
Mushroom Market requires legalization and branches into wellness
retreats, treatment certifications and clinics.
MSRM is also evaluating several
companies involved in the Myco-Remediation Market which uses fungi
to clean oil spills, heavy metals, plastics and other pollutants
from soil, water, and the atmosphere. All of these markets relate to the industrial
and health innovation that the Company is pursuing in differing
aspects and creates a connecting point for acceleration, mutual
benefit and market share.
It is the belief of MSRM that
connecting these pillars of the mushroom market through joint
ventures and acquisitions, while focusing their innovation efforts
on the industrial side of the market, will garner cross benefits
financially and accelerate timelines during the major research and
development phases.
We are simultaneously creating a
vertically integrated business model for the businesses involved by
aligning strengths between the companies under the umbrella of
MSRM.
From an investor perspective, we
are creating an avenue for investors to support a larger portion of
the mushroom market, establishing a broader financial base of
support for and from the networked companies while allowing for a
more elastic ability to pivot, expand and connect to new industry
pathways as they surface.
Market
Opportunity
Mushrooms, Inc. operates in the
North American segment of the functional mushroom market in the
mycelium material and mushroom supplement product types. According
to various industrial research firms, the global functional
mushroom market is projected to show a compounded annual growth
rate of over 9% for the next five years (Industry Arc and Vantage
Market Research). The North American edible mushroom market was
worth 11.99 billion in 2023 and is growing at a compounded annual
growth rate of 9.48%, forecast to reach 20.91 billion by 2028
(Market Data Forecast). The North American functional mushroom
market held 33.8% of the global market in 2020 and is growing at a
compounded annual growth rate of 7% (Industry Arc).
Overview
Mushrooms, Inc. is a
developing-stage emerging consumer products platform focused on the
manufacturing and marketing of highly differentiated mushroom-based
materials and functional supplements. The core growth pillars of
the Mushrooms, Inc. platform are currently based on developing
functional mushroom technologies. As a result of growing consumer
demand for innovative, sustainable, and carbon-neutral products,
Mushrooms, Inc. plans to grow revenues by penetrating the
multi-billion-dollar market opportunity currently being opened by
new mycelium-based materials science and biotechnology, as well as
expanding our platform to include the creation of supplements based
on the proven health benefits of mushrooms.
Mushrooms, Inc. seeks to drive the
growth of the bourgeoning functional mushroom industry through
product innovation and development. Our current core business
activity is environmentally beneficial product innovation utilizing
self-growing, fibrous, and natural composite materials with
controlled physical properties that can be produced in large
quantities. Our product technologies focus on mycelium, the main
component of fungi. This emerging biotechnology is used in the
creation of carbon neutral products for the building, textile,
packaging, and health care industries, as well as in the creation
of supplements based on the proven health benefits of
mushrooms.
Currently, our research focuses
primarily on the significant thermal stability of mycelium
materials, a result of mycelium's unique degradation qualities that
expand the potential fields of application for mushroom-based
products. Mushrooms, Inc.'s long-term goal is to build a strong
scalable and widely recognized brand that authentically focuses on
sustainable mushroom ingredients and novel functionality stemming
from innovative biotech and materials science.
For more information, email
info@mushroomsinc.com or visit
www.mushroomsinc.com
Safe Harbor
Statement
This release contains
forward-looking statements that are based upon current expectations
or beliefs, as well as a number of assumptions about future events.
Although we believe that the expectations reflected in the
forward-looking statements and the assumptions upon which they are
based are reasonable, we can give no assurance or guarantee that
such expectations and assumptions will prove to have been correct.
Forward-looking statements are generally identifiable by the use of
words like "may," "will," "should," "could," "expect,"
"anticipate," "estimate," "believe," "intend," or "project" or the
negative of these words or other variations on these words or
comparable terminology. The reader is cautioned not to put undue
reliance on these forward-looking statements, as these statements
are subject to numerous factors and uncertainties, including but
not limited to: adverse economic conditions, competition, adverse
federal, state and local government regulation, international
governmental regulation, inadequate capital, inability to carry out
research, development and commercialization plans, loss or
retirement of key executives and other specific risks. To the
extent that statements in this press release are not strictly
historical, including statements as to revenue projections,
business strategy, outlook, objectives, future milestones, plans,
intentions, goals, future financial conditions, events conditioned
on stockholder or other approval, or otherwise as to future events,
such statements are forward-looking, and are made pursuant to the
safe harbor provisions of the Private Securities Litigation Reform
Act of 1995. The forward-looking statements contained in this
release are subject to certain risks and uncertainties that could
cause actual results to differ materially from the statements
made.
Corporate
Contact:
Mushrooms,
Inc.
CEO: Kimberly Carlson
Tel: (877) 379-5400
email: info@mushroomsinc.com